Ceftolozane/tazobactam: Literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012–2021)
Autor: | Chien-Ming Chao, Wen-Liang Yu |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Heliyon, Vol 10, Iss 13, Pp e33114- (2024) |
Druh dokumentu: | article |
ISSN: | 2405-8440 |
DOI: | 10.1016/j.heliyon.2024.e33114 |
Popis: | Ceftolozane, a novel cephalosporin, combined with tazobactam, a known β-lactamase inhibitor, shows robust antipseudomonal activity, although it doesn't cover carbapenemases. Our review of data from 2012 to 2021 in Taiwan highlights TOL/TAZ's in-vitro performance.TOL/TAZ is most effective against Pseudomonas aeruginosa (91.3–94.4 % susceptible, with an MIC |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |